Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)
J. R. Hemsath, M. Liaci, J. Rubin, B. Parrett, S.-C. Lu, T. Nguyen, M. Turner, C. Chen, V. S. Reddy, K. Cupelli, T. Stehle, K. Liszewski, J. Atkinson, M. A. Barry
This paper investigates the CD46 receptor utilization by Ad26 in vitro and in vivo, showing its role in infection and safety, but not all routes of administration.
Journal of Virology · Feb 9, 2022Peer-reviewedPharmacology & Toxicology